Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 2, keine Gesamtzahl für „components“
Suchtreffer
Begriffe & Kennungen
Descovy · 4.5 · 32 Table 2: Interactions between the individual components of Descovy and other medicinal products
Eintrag öffnenDescovy · 4.5 · 6 Table 2: Interactions between the individual components of Descovy and other medicinal products
Eintrag öffnenDescovy · 4.5 · Interactions between the components of Descovy and potential co-administered medicinal products are listed in
Eintrag öffnenDescovy · 4.5 · Interactions between the components of Descovy and potential co-administered medicinal products are listed in
Eintrag öffnenDovato · 4.8 · There are no clinical study data on the effects of Dovato in the paediatric population. Individual components
Eintrag öffnenDuaklir Genuair · 4.8 · Adverse reactions associated with Duaklir Genuair were similar to those of the individual components. As Duakl
Eintrag öffnenEmtricitabine/Tenofovir disoproxil Mylan · 4.8 · 28 Table 3: Tabulated summary of adverse reactions associated with the individual components of emtricitabine/
Eintrag öffnenEmtricitabine/Tenofovir disoproxil Mylan · 4.8 · The adverse reactions considered at least possibly related to treatment with the components of emtricitabine/t
Eintrag öffnenEreigniskorrelierte Potentiale, P300-
Eintrag öffnenEucreas · 4.8 · Table 1 Adverse reactions reported in patients who received vildagliptin and metformin (as mono-components or
Eintrag öffnenEviplera · 4.8 · The adverse reactions considered at least possibly related to treatment with the components of Eviplera from c
Eintrag öffnenEviplera · 4.8 · When emtricitabine (one of the components of Eviplera) was administered to paediatric patients, the following
Eintrag öffnenExforge · 4.8 · Additional information on the individual components
Eintrag öffnenExforge · 4.8 · Adverse reactions previously reported with one of the individual components (amlodipine or valsartan) may be p
Eintrag öffnenFluad · 4.3 · Hypersensitivity to the active substances, to any of the components of the adjuvant, to any of the excipients
Eintrag öffnenGazyvaro · 4.8 · infusion that were judged by the investigator to be related to any components of therapy. b C1 comprised three
Eintrag öffnenGen-Bestandteile
Eintrag öffnenGenomkomponenten
Eintrag öffnenGenvoya · 4.5 · 8 Table 1: Interactions between the individual components of Genvoya and other medicinal products
Eintrag öffnenGenvoya · 4.5 · Based on drug-drug interaction studies conducted with Genvoya or the components of Genvoya, no clinically sign
Eintrag öffnen